ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

March 7, 2014

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

NCI to Establish Three Grants Programs Supporting Clinical Cancer Research

February 18, 1994